Close Menu

NEW YORK – Cancer Genetics said on Thursday after the close of the market that it has signed securities purchase agreements with unnamed institutional and accredited investors to raise about $10 million through the issuance of stock and warrants.

In the private placement, Rutherford, New Jersey-based Cancer Genetics will sell 2,758,624 shares of its common stock as well as warrants to purchase an additional 2,758,624 shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.